Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed families

A Alex Dulovic A Armin Rabsteyn J Jonathan Remppis I Irene K. E. Gentzcke J Julia Mueller N Nadja Tuecks M Matthias Becker D Daniel Junker P Philipp D. Kaiser B Bjoern Traenkle U Ulrich Rothbauer J Juliane S. Walz A Andreas Peter S Sebastian Hörber T Tina Ganzenmueller T Thomas Iftner M Maximilian Stich B Burkhard Tönshoff (Department of Pediatrics I, University Children Hospital Heidelberg, Heidelberg, Germany) P Philipp Henneke R Roland Elling (Institute for Immunodeficiency, Center of Chronic Immunodeficiency, University Medical Center, Faculty of Medicine, University of Freiburg) K Klaus-Michael Debatin A Ales Janda N Nicole Schneiderhan-Marra A Axel R. Franz P Peter Lang H Hanna Renk

Abstract

Abstract Identification of previous SARS-CoV-2 infection typically relies on serology, yet T-cells play a key role in the adaptive immune response against SARS-CoV-2. Here, we investigated in parallel the SARS-CoV-2-specific as well as endemic human coronavirus-specific humoral and cross-reactive cellular responses in children and adults. We analyzed clinical data and blood samples from a family cohort of 96 children and 144 adults at 3–4 and 11–12 months after their first contact with SARS-CoV-2. Humoral response was assessed by a multiplex immunoassay with high sensitivity and specificity (MULTICOV-AB). Cellular responses were analyzed by IFN-γ ELISPOT using four different established epitope compositions (ECs) to discriminate between SARS-CoV-2 specific and HCoV cross-reactive T-cell responses. While the majority of adults had a combined serological and T-cell response, relatively more children had a T-cell response alone rather than a combined response. The magnitude of the T-cell response correlated with symptoms and the humoral response. In addition, SARS-CoV-2 infection significantly boosted the endemic coronavirus-specific cellular response. Overall, our data suggest discordant humoral and cellular responses, reflecting either abortive infection, cellular sensitization with rapid viral clearance or rapid antibody waning or a combination of these phenomena. Restricting epidemiologic analysis to SARS-CoV-2 serological data may underestimate rates of infection with or at least exposure to SARS-CoV-2 in children.

Article Details

Volume / Issue Vol. 15, Issue 1
Published July 18, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (26)

A

Alex Dulovic

A

Armin Rabsteyn

J

Jonathan Remppis

I

Irene K. E. Gentzcke

J

Julia Mueller

N

Nadja Tuecks

M

Matthias Becker

D

Daniel Junker

P

Philipp D. Kaiser

B

Bjoern Traenkle

U

Ulrich Rothbauer

J

Juliane S. Walz

A

Andreas Peter

S

Sebastian Hörber

T

Tina Ganzenmueller

T

Thomas Iftner

M

Maximilian Stich

B

Burkhard Tönshoff

Department of Pediatrics I, University Children Hospital Heidelberg, Heidelberg, Germany

P

Philipp Henneke

R

Roland Elling

Institute for Immunodeficiency, Center of Chronic Immunodeficiency, University Medical Center, Faculty of Medicine, University of Freiburg

K

Klaus-Michael Debatin

A

Ales Janda

N

Nicole Schneiderhan-Marra

A

Axel R. Franz

P

Peter Lang

H

Hanna Renk